Cover Image
市場調查報告書

Adiga Life Sciences Inc. - 產品平台分析

Adiga Life Sciences Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 310645
出版日期 內容資訊 英文 16 Pages
訂單完成後即時交付
價格
Back to Top
Adiga Life Sciences Inc. - 產品平台分析 Adiga Life Sciences Inc. - Product Pipeline Review - 2014
出版日期: 2014年08月14日 內容資訊: 英文 16 Pages
簡介

Adiga Life Sciences Inc. 是提供及管理生命科學研究發展用資金,並研究醫療科學技術的公司。該公司同時也致力於過敏疾病及自體免疫疾病的免疫功能技術之開發。另外更著手研究開發各種治療藥。

本報告提供Adiga Life Sciences Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Adiga Life Sciences Inc.的基本資料

Adiga Life Sciences Inc.概要

  • 主要資訊
  • 企業資料

Adiga Life Sciences Inc.:R&D概要

  • 主要的治療範圍

Adiga Life Sciences Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Adiga Life Sciences Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

Adiga Life Sciences Inc.:藥物簡介

  • Peptide Vaccine for Rheumatoid Arthritis
  • Vaccine for Birch Tree Pollen Allergy
  • Vaccine for Japanese Cedar Pollen Allergy

Adiga Life Sciences Inc.

  • 各分子類型

Adiga Life Sciences Inc.:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06137CDB

Summary

Global Markets Direct's, 'Adiga Life Sciences Inc. - Product Pipeline Review - 2014', provides an overview of the Adiga Life Sciences Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Adiga Life Sciences Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Adiga Life Sciences Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Adiga Life Sciences Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Adiga Life Sciences Inc.'s pipeline products

Reasons to buy

  • Evaluate Adiga Life Sciences Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Adiga Life Sciences Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Adiga Life Sciences Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Adiga Life Sciences Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Adiga Life Sciences Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Adiga Life Sciences Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Adiga Life Sciences Inc. Snapshot
    • Adiga Life Sciences Inc. Overview
    • Key Information
    • Key Facts
  • Adiga Life Sciences Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Adiga Life Sciences Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Adiga Life Sciences Inc. - Pipeline Products Glance
    • Adiga Life Sciences Inc. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Adiga Life Sciences Inc. - Drug Profiles
    • Peptide Vaccine for Rheumatoid Arthritis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Birch Tree Pollen Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Japanese Cedar Pollen Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Adiga Life Sciences Inc. - Pipeline Products by Molecule Type
  • Adiga Life Sciences Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Adiga Life Sciences Inc., Key Information
  • Adiga Life Sciences Inc., Key Facts
  • Adiga Life Sciences Inc. - Pipeline by Indication, 2014
  • Adiga Life Sciences Inc. - Pipeline by Stage of Development, 2014
  • Adiga Life Sciences Inc. - Monotherapy Products in Pipeline, 2014
  • Adiga Life Sciences Inc. - Discovery, 2014
  • Adiga Life Sciences Inc. - Pipeline by Molecule Type, 2014

List of Figures

  • Adiga Life Sciences Inc. - Pipeline by Top 10 Indication, 2014
Back to Top